INN name:
|
Belizatinib
|
||||||
Lab codes:
|
TSR-011
|
||||||
Chemical
name:
|
4-fluoro-N-(6-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-1-{cis-4-[(propan-2-yl)carbamoyl]cyclohexyl}-1H-benzimidazol-2-yl)benzamide
|
||||||
Molecular
formula:
|
C33H44FN5O3
|
||||||
Chemical
Structure:
|
 |
||||||
CAS Registry
Number:
|
1357920-84-3
|
||||||
Originator:
|
Amgen
|
||||||
Developer:
|
TESARO
|
||||||
Class:
|
Antineoplastics
|
||||||
Mechanism of
Action:
|
Anaplastic
lymphoma kinase inhibitors; Trosine kinase inhibitor
|
||||||
WHO ATC code:
|
L01X-E
(Protein kinase inhibitors)
|
||||||
EPhMRA code:
|
L1H
(Protein Kinase Inhibitor Antineoplastics)
|
||||||
Clinical Trials:
|
|||||||
Product Patent Expiry:
For patent data contact
us at drugpatentexpiry@gmail.com
|
|||||||
Tuesday, 8 September 2015
Belizatinib
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment